NCT06823895View on ClinicalTrials.gov

Pharmacokinetic Study of Oligonucleotides in Maixuekang Capsules

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 25, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Healthy
Interventions
DRUG

Maixuekang capsule

"Single dose group: Participants will be given Maixuekang capsules once, 1g, orally.~Multiple dose group: Participants will receive 1g of Maixuekang capsules orally for 3 days, 3 times a day."

Trial Locations (1)

Unknown

RECRUITING

Nanfang Hospital, Southern Medical University, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER